NUVALENT INC's ticker is and the CUSIP is 670703107. A total of 92 filers reported holding NUVALENT INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $16 | 0.0% | 217 | 0.0% | 0.00% | – |
Q1 2024 | $16 | -5.9% | 217 | -7.3% | 0.00% | – |
Q4 2023 | $17 | +88.9% | 234 | +14.1% | 0.00% | – |
Q3 2023 | $9 | 0.0% | 205 | 0.0% | 0.00% | – |
Q2 2023 | $9 | +80.0% | 205 | 0.0% | 0.00% | – |
Q1 2023 | $5 | -16.7% | 205 | 0.0% | 0.00% | – |
Q4 2022 | $6 | -99.7% | 205 | +64.0% | 0.00% | – |
Q3 2022 | $2,000 | 0.0% | 125 | 0.0% | 0.00% | – |
Q2 2022 | $2,000 | 0.0% | 125 | 0.0% | 0.00% | – |
Q1 2022 | $2,000 | 0.0% | 125 | 0.0% | 0.00% | – |
Q4 2021 | $2,000 | – | 125 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 19,991,024 | $843,021,482 | 18.00% |
Fairmount Funds Management LLC | 2,884,492 | $121,639,028 | 17.15% |
Bain Capital Life Sciences Investors, LLC | 3,577,267 | $150,853,349 | 15.54% |
COMMODORE CAPITAL LP | 1,150,000 | $48,495,500 | 5.45% |
Paradigm Biocapital Advisors LP | 1,120,465 | $47,250,009 | 3.65% |
Perceptive Advisors | 2,194,821 | $92,555,602 | 2.68% |
Boxer Capital, LLC | 1,210,192 | $51,034 | 2.37% |
Ikarian Capital, LLC | 272,752 | $11,501,952 | 1.83% |
SILVERARC CAPITAL MANAGEMENT, LLC | 115,067 | $4,852,375 | 1.50% |
HighVista Strategies LLC | 72,298 | $3,048,807 | 1.40% |